BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 2993307)

  • 1. A heterozygous collagen defect in a variant of the Ehlers-Danlos syndrome type VII. Evidence for a deleted amino-telopeptide domain in the pro-alpha 2(I) chain.
    Eyre DR; Shapiro FD; Aldridge JF
    J Biol Chem; 1985 Sep; 260(20):11322-9. PubMed ID: 2993307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo and in vitro noncovalent association of excised alpha 1 (I) amino-terminal propeptides with mutant pN alpha 2(I) collagen chains in native mutant collagen in a case of Ehlers-Danlos syndrome, type VII.
    Wirtz MK; Keene DR; Hori H; Glanville RW; Steinmann B; Rao VH; Hollister DW
    J Biol Chem; 1990 Apr; 265(11):6312-7. PubMed ID: 2318855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A base substitution at the splice acceptor site of intron 5 of the COL1A2 gene activates a cryptic splice site within exon 6 and generates abnormal type I procollagen in a patient with Ehlers-Danlos syndrome type VII.
    Chiodo AA; Hockey A; Cole WG
    J Biol Chem; 1992 Mar; 267(9):6361-9. PubMed ID: 1556139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of 24 amino acids from the pro-alpha 1(I) chain of type I procollagen in a patient with the Ehlers-Danlos syndrome type VII.
    Cole WG; Chan D; Chambers GW; Walker ID; Bateman JF
    J Biol Chem; 1986 Apr; 261(12):5496-503. PubMed ID: 3082886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ehlers-Danlos syndrome type VIIB. Deletion of 18 amino acids comprising the N-telopeptide region of a pro-alpha 2(I) chain.
    Wirtz MK; Glanville RW; Steinmann B; Rao VH; Hollister DW
    J Biol Chem; 1987 Dec; 262(34):16376-85. PubMed ID: 3680255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical features of Ehlers-Danlos syndrome type VIIB resulting from a base substitution at the splice acceptor site of intron 5 of the COL1A2 gene.
    Carr AJ; Chiodo AA; Hilton JM; Chow CW; Hockey A; Cole WG
    J Med Genet; 1994 Apr; 31(4):306-11. PubMed ID: 8071956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further evidence that the failure to cleave the aminopropeptide of type I procollagen is the cause of Ehlers-Danlos syndrome type VII.
    Ho KK; Kong RY; Kuffner T; Hsu LH; Ma L; Cheah KS
    Hum Mutat; 1994; 3(4):358-64. PubMed ID: 8081389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A base substitution at a splice site in the COL3A1 gene causes exon skipping and generates abnormal type III procollagen in a patient with Ehlers-Danlos syndrome type IV.
    Cole WG; Chiodo AA; Lamande SR; Janeczko R; Ramirez F; Dahl HH; Chan D; Bateman JF
    J Biol Chem; 1990 Oct; 265(28):17070-7. PubMed ID: 2145268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for a structural mutation of procollagen type I in a patient with the Ehlers-Danlos syndrome type VII.
    Steinmann B; Tuderman L; Peltonen L; Martin GR; McKusick VA; Prockop DJ
    J Biol Chem; 1980 Sep; 255(18):8887-93. PubMed ID: 6773953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of an altered type III procollagen in a patient with type IV Ehlers-Danlos syndrome. A structural change in the alpha 1(III) chain which makes the protein more susceptible to proteinases.
    Stolle CA; Pyeritz RE; Myers JC; Prockop DJ
    J Biol Chem; 1985 Feb; 260(3):1937-44. PubMed ID: 2981879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ehlers-Danlos syndrome type VII: a single base change that causes exon skipping in the type I collagen alpha 2(I) chain.
    Nicholls AC; Oliver J; Renouf DV; McPheat J; Palan A; Pope FM
    Hum Genet; 1991 Jun; 87(2):193-8. PubMed ID: 1712342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ehlers Danlos syndrome type VIIB. Incomplete cleavage of abnormal type I procollagen by N-proteinase in vitro results in the formation of copolymers of collagen and partially cleaved pNcollagen that are near circular in cross-section.
    Watson RB; Wallis GA; Holmes DF; Viljoen D; Byers PH; Kadler KE
    J Biol Chem; 1992 May; 267(13):9093-100. PubMed ID: 1577745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human dermatosparaxis: a form of Ehlers-Danlos syndrome that results from failure to remove the amino-terminal propeptide of type I procollagen.
    Smith LT; Wertelecki W; Milstone LM; Petty EM; Seashore MR; Braverman IM; Jenkins TG; Byers PH
    Am J Hum Genet; 1992 Aug; 51(2):235-44. PubMed ID: 1642226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiexon deletion in the procollagen III gene is associated with mild Ehlers-Danlos syndrome type IV.
    Vissing H; D'Alessio M; Lee B; Ramirez F; Byers PH; Steinmann B; Superti-Furga A
    J Biol Chem; 1991 Mar; 266(8):5244-8. PubMed ID: 2002056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Various characteristics of the structure and synthesis of procollagens produced by cultured skin fibroblasts from patients with Danlos-Ehlers syndrome type I].
    Sokolov BP; Sher BM; Lomova TIu; Kukharenko VI; Blinnikova OE
    Mol Gen Mikrobiol Virusol; 1987 Jan; (1):19-23. PubMed ID: 3561422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a mutation that causes exon skipping during collagen pre-mRNA splicing in an Ehlers-Danlos syndrome variant.
    Weil D; Bernard M; Combates N; Wirtz MK; Hollister DW; Steinmann B; Ramirez F
    J Biol Chem; 1988 Jun; 263(18):8561-4. PubMed ID: 2454224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical features of Ehlers-Danlos syndrome type VII due to a deletion of 24 amino acids from the pro alpha 1(I) chain of type I procollagen.
    Cole WG; Evans R; Sillence DO
    J Med Genet; 1987 Nov; 24(11):698-701. PubMed ID: 3430546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An exon skipping mutation of a type V collagen gene (COL5A1) in Ehlers-Danlos syndrome.
    Nicholls AC; Oliver JE; McCarron S; Harrison JB; Greenspan DS; Pope FM
    J Med Genet; 1996 Nov; 33(11):940-6. PubMed ID: 8950675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural and functional characterization of a splicing mutation in the pro-alpha 2(I) collagen gene of an Ehlers-Danlos type VII patient.
    Weil D; D'Alessio M; Ramirez F; Eyre DR
    J Biol Chem; 1990 Sep; 265(26):16007-11. PubMed ID: 2394758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation of collagen from the skins of Ehlers-Danlos syndrome-affected dogs by acetic acid extraction and pepsin digestion.
    Counts DF
    Biochim Biophys Acta; 1980 Nov; 626(1):208-17. PubMed ID: 6779875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.